Giffard, Julia https://orcid.org/0009-0009-1718-4161
Li, Renjie https://orcid.org/0000-0003-2374-5067
Roccati, Eddy https://orcid.org/0000-0002-7587-9051
Vogel, Adam P. https://orcid.org/0000-0002-3505-2631
Bindoff, Aidan D. https://orcid.org/0000-0002-0943-2702
Goldberg, Lynette R. https://orcid.org/0000-0002-8217-317X
Bai, Quan https://orcid.org/0000-0003-1214-6317
Alty, Jane https://orcid.org/0000-0002-5456-8676
Funding for this research was provided by:
National Health and Medical Research Council (2004051)
Department of Health and Aged Care, Australian Government (MRFF1170820)
Australian Research Council (FT220100253)
Department of Education, Australian Government (Research Training Program (RTP) Scholarship)
University of Tasmania
Article History
Received: 18 March 2025
Accepted: 4 June 2025
First Online: 24 June 2025
Declarations
:
: ISLAND and TAS Test were approved by the University of Tasmania Human Research Ethics Committee (H0018264 and H0021660, respectively) in accordance with the guidelines of the National Health and Medical Research Council. Informed consent was provided by all participants.
: All authors and named contributors have provided consent for publication.
: A. P. Vogel is Chief Science Officer of Redenlab Inc. The remaining authors declare no conflicts of interest.